Menu

Blog

Archive for the ‘biotech/medical’ category: Page 231

Jul 11, 2023

Blood Test Plus Personalized Model May Predict Lung Cancer Death Risk

Posted by in categories: biotech/medical, futurism

The USPSTF recommends that adults at elevated risk for lung cancer receive a low-dose CT scan each year, which was shown to reduce lung cancer deaths in the 2011 National Lung Screening Trial (NLST). The 2021 USPSTF criteria applies to adults aged 50 to 80 who have at least a 20 PY smoking history and currently smoke or have quit within the past 15 years.

“For individuals who currently are not eligible for lung cancer screening, a positive test may help to identify those possibly at risk for lung cancer death,” said co-corresponding author Edwin Ostrin, MD, PhD, assistant professor of general internal medicine. “We envision this as a tool that could be deployed worldwide, as the future of early detection of this disease.”

Lung cancer causes an estimated 25% of cancer deaths. Early detection improves prospects of survival, but most countries do not screen for it. Fewer than half of all U.S. cases are among people who are eligible under USPSTF guidelines.

Jul 11, 2023

New views of a cough: From TB and chronic cough to hope for Parkinson’s

Posted by in categories: biotech/medical, health

Michael Shiloh had been studying tuberculosis for about two decades when he started wondering about a seemingly basic question: What makes people with TB cough? This is the disease’s hallmark symptom and a main mode of transmission, but despite training as an infectious disease physician and many years of probing the pathogen as a researcher, Shiloh realized that he didn’t know. A quick search of the literature suggested that “essentially nothing had been studied about it, at least not at the molecular level,” he says.

Elucidating the role of cough in illness means first appreciating its role in health. “Cough is one of these critical defensive processes that we have to clear the respiratory system,” says Stuart Mazzone, a neuroscientist at the University of Melbourne. But it also contributes to disease spread, as research by Shiloh, now at the University of Texas Southwestern Medical Center, and others has described. And dysfunctional control of coughing — resulting in too much coughing or not enough — can cause serious health problems.

Here’s a look at how and why we cough, and some of the ways that coughing can go wrong.

Jul 11, 2023

Single-Cell RNA Sequencing Provides Novel Insights into Gastric Cancer Progression

Posted by in categories: biotech/medical, evolution

The findings are published in Cancer Cell in an article titled, “Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.”

“Understanding tumor microenvironment (TME) reprogramming in gastric adenocarcinoma (GAC) progression may uncover novel therapeutic targets,” wrote the researchers. “Here, we performed single-cell profiling of precancerous lesions, localized and metastatic GACs, identifying alterations in TME cell states and compositions as GAC progresses. Abundant IgA+ plasma cells exist in the premalignant microenvironment, whereas immunosuppressive myeloid and stromal subsets dominate late-stage GACs.”

“Gastric adenocarcinoma exhibits a high degree of heterogeneity with respect to both its phenotypes and molecular characteristics, but research around it has lagged behind other cancer types,” explained Linghua Wang, MD, PhD, associate professor of genomic medicine. “Most studies have concentrated on tumor cells and largely overlooked the immune and stromal cells within the tumor microenvironment, which are very dynamic and play critical roles in cancer progression. This study represents the largest single-cell RNA sequencing cohort of gastric adenocarcinoma to date and brings important new insights into how these cell populations impact disease progression.”

Jul 11, 2023

Biologists identify mechanical waves involved in limb regeneration in zebrafish

Posted by in category: biotech/medical

A team of molecular and cellular biologists from several institutions in Taiwan and one in the Philippines has identified some of the mechanical waves involved in the regeneration of amputated tailfins in zebrafish. In their study, reported in the journal Nature Physics, the group studied zebrafish regrowth after their tailfins were removed.

Prior research has shown that many have the ability to regrow (mostly appendages) when they are lost, typically after incidents of fighting or hunting. Prior research has also shown that for most such creatures, the amount of regrowth is proportional to the amount lost. The generation of mechanical waves are known to play a role in controlling epithelial cell expansion, the means by which new tissues are generated.

Continue reading “Biologists identify mechanical waves involved in limb regeneration in zebrafish” »

Jul 11, 2023

Is our world ready for mind-controllable robotic body parts?

Posted by in categories: biotech/medical, cyborgs, internet, robotics/AI

Advanced neuroprosthetics are here, and they could hook our brains into the Internet of Things.

Jul 10, 2023

Guide to Colorblindness

Posted by in category: biotech/medical

Caused by genes, disease, or medicine color blindness is diagnosed using the Ishiara color test. Learn more about about the gadgets and habits that some people with color deficiency use to live with it and to explore the prospects of various treatments.

Jul 10, 2023

Scientists working on ‘universal’ flu vaccine that could last years

Posted by in category: biotech/medical

Wouldn’t it be nice to get a flu shot that could last for years? Researchers are actively working on a so-called “universal” flu vaccine.

Jul 10, 2023

New Study Paves Way For Personalized Medicine For Infections

Posted by in category: biotech/medical

Researchers at Tel Aviv University (TAU) say they have identified two key components of the body’s immune response to severe infectious disease, potentially paving the way for personalized and more effective treatments in the field of infectious diseases.

An infectious disease is caused by a microorganism such as a bacterium or a virus entering the body and causing damage to the cells. These cells can also be damaged by the immune system fighting the infection, such as in the case of inflammation.

The body’s reaction to infection has previously been viewed as a monolithic unit, but now the TAU researchers have been able to locate two main markers in the blood that are triggered by infection.

Jul 10, 2023

Hybrid Model for RNA Bioprocessing

Posted by in categories: biotech/medical, chemistry, robotics/AI

When asked how this model can cover such a broad scale, Xie says, that it “is rooted in the integration of mechanistic modeling and ML statistical methods, which allows the model to provide a more comprehensive and nuanced understanding of various aspects of RNA and related processes, while quantifying uncertainties due to limited knowledge.”

For example, she explains that, “The mechanistic aspect of the model captures intricate physical and chemical properties at the atomic level, which supports a deep understanding of the underlying biological processes, and the machine-learning element can effectively capture patterns in complex datasets—such as molecular simulations and single-molecule fluorescence microscopy time-course data—and learn relationships that might not be explicitly described in existing mechanistic models.”

In addition to helping scientists better understand the fundamental biology of RNA, the Northeastern team’s hybrid model promises many commercial benefits in the production of monoclonal antibodies, cell and gene therapies, and mRNA vaccines. As Xie says, “It can advance the knowledge of RNA manufacturing mechanisms and guide simultaneous design/control strategies at different levels, such as RNA sequence selection and specifications of critical quality attributes, with less experiments.”

Jul 10, 2023

Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers

Posted by in categories: biotech/medical, life extension, neuroscience

A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options and are often associated with poor outcomes.

This subset of cancers makes up 15% of all cancers and is especially prevalent in aggressive tumors such as osteosarcoma (bone tumor) and glioblastoma (brain tumor).

These cancerous cells stay “immortal” using a mechanism called the alternative lengthening of telomeres (ALT), but the team has demonstrated that ponatinib, a cancer approved by the US Food and Drug Administration, blocks key steps in the ALT mechanism that leads it to fail.

Page 231 of 2,403First228229230231232233234235Last